Cell Therapy and Cell Engineering Facility
Overview
Xiuyan Wang
Director
The Cell Therapy and Cell Engineering Facility develops, validates, and implements procedures critical to gene transfer-related clinical research at Memorial Sloan Kettering. The quality assurance and quality control unit (QA/QC) is essential for providing a laboratory environment compliant with NIH and FDA guidelines.
Featured News
Testing CRISPR-Edited CAR T Cell Therapy in Lymphoma Clinical Trial
A groundbreaking clinical trial is testing CAR T cells created using CRISPR gene-editing technology.
Feature
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Clinical Trial for Beta-Thalassemia Brings Important Insights for Treating Blood Disorders with Stem Cell Gene Therapy
A gene therapy approach could prove effective at treating an inherited blood disorder called beta (β)-thalassemia.
People
Members
Jagruti Chaudhari
Tasmin Farzana
Maria Freeman
Paridhi Gautam
Amy Guzman
Laboratory Quality Assurance Coordinator
Melanie Hall
Lissa Rojas
Keyur Thummar
Nicholas Yeomans
Juan Zhen
Alumni
Open Positions
To learn more about available postdoctoral opportunities, please visit our Career Center
Get in Touch
-
Director Email
-
Director Email
-
Director Email